AMUNDI ASSET MANAGEMENT US, INC. - PDL BIOPHARMA INC ownership

Quarter-by-quarter ownership
AMUNDI ASSET MANAGEMENT US, INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2016$13,828,000
+1.5%
14,237,000
-1.0%
0.05%
+2.0%
Q2 2016$13,621,000
+4.9%
14,375,0000.0%0.05%
+2.1%
Q1 2016$12,982,000
+12.8%
14,375,0000.0%0.05%
+11.6%
Q4 2015$11,510,000
-9.1%
14,375,0000.0%0.04%
-17.3%
Q3 2015$12,668,000
-7.1%
14,375,0000.0%0.05%
+4.0%
Q2 2015$13,629,000
-0.9%
14,375,0000.0%0.05%
+2.0%
Q1 2015$13,755,000
+0.1%
14,375,0000.0%0.05%
-2.0%
Q4 2014$13,747,000
-1.8%
14,375,0000.0%0.05%
-5.7%
Q3 2014$13,998,000
-32.1%
14,375,000
-20.1%
0.05%
-32.9%
Q2 2014$20,611,000
+8.8%
18,000,0000.0%0.08%
+9.7%
Q1 2014$18,945,00018,000,0000.07%
Other shareholders

There were no reported owners of PDL BIOPHARMA INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of PDL BIOPHARMA INC shareholders